Skip to main navigation
PMVPharma logo

Press Releases

Sep 08, 2026 PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
Aug 31, 2026 PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
Aug 31, 2026 PMV Pharma Announces Proposed Public Offering of Securities
Aug 31, 2026 PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
Aug 14, 2026 PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026 PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
Apr 22, 2026 PMV Pharmaceuticals Announces Board Chair Transition
Mar 06, 2026 PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Feb 26, 2026 New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors

Site - Investor Tools

  • Print
  • Email Alerts
  • RSS Feeds
  • Contact IR
  • Email Page
  • Overview
  • Press Releases
  • Events, Presentations & Publications
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Corporate Governance
    • Governance Overview
    • Committee Composition
  • ESG
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
  • Shareholder Services
    • FAQ
    • Email Alerts
    • Contact IR
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Boards
  • Science
    • p53 Overview
    • p53 and Cancer
    • Drug Discovery
  • Pipeline
    • PMV Pipeline
    • PC14586
    • Clinical Trials
    • Access to Investigational Product
  • Investors
    • Overview
    • Press Releases
    • Events, Presentations & Publications
    • Financial & Filings
    • Corporate Governance
    • ESG
    • Stock Information
    • Shareholder Services
  • Life at PMV
    • Working at PMV
    • Job Opportunities
  • Contact

Site - Mobile

  • Home
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • p53 Overview
    • p53 and Cancer
    • Drug Discovery
  • Pipeline
    • PMV Pipeline
    • PC14586
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
      • SEC Filings
      • Quarterly Results
    • Corporate Governance
      • Governance Overview
      • Committee Composition
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • Shareholder Services
      • FAQ
      • Email Alerts
      • Contact IR
  • Life at PMV
    • Working at PMV
    • Job Opportunities
  • Contact
  • Terms of Use
  • Privacy Policy

PMVPharma White Logo

© 2026 PMV Pharmaceuticals, Inc. All rights reserved
  • Terms of Use
  • Privacy Policy